Skip to main content
. 2016 Jul 8;11(7):e0158135. doi: 10.1371/journal.pone.0158135

Table 1. Dosimetry and cell viability after 18 GHZ EMF exposure.

Cell types Taxonomy affiliation Dosimetry Cell viability
Doses SAR (kW/kg) 33°C 40°C
Branhamella catarrhalis ATCC 23246* Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae; Moraxella; Branhamella 3 5 N/A 96% ± 7%
Escherichia coli K 12 Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Escherichia 3 5 N/A 88% ± 4%
Kocuria rosea CIP 71.15T* Bacteria; Actinobacteria; Actinobacteria; Actinobacteridae; Micrococcales; Micrococcaceae; Kocuria 3 3 98% ± 7% 62% ± 10%
Planococcus maritimus KMM 3738 Bacteria; Firmicutes; Bacilli; Bacillales; Planococcaceae; Planococcus 3 5 N/A 85% ± 8%
Staphylococcus aureus ATCC 25923 Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus 3 5 N/A 85% ± 5%
Staphylococcus aureus CIP 65.8T Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus 3 5 N/A 89% ± 5%
Staphylococcus epidermidis ATCC 14990T Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus 3 5 N/A 84% ± 9%
Streptomyces griseus ATCC 23915* Bacteria; Actinobacteria; Actinobacteria; Actinobacteridae; Streptomycetales; Streptomycetaceae; Streptomyces; Streptomyces griseus group; Streptomyces griseus subgroup 3 5 N/A 97% ± 7%
Saccharomyces cerevisiae ATCC 287* Eukaryota; Opisthokonta; Fungi; Dikarya; Ascomycota; saccharomyceta; Saccharomycotina; Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces 6 3 94% ± 8% 47% ± 8%

*Data from this study.

The cell viability, expressed as a percentage, was calculated by direct counting the colony forming units present on the plates. The data are mean values, with errors being the standard deviation (SD). Results are representative of 3 independent experiments. N/A: not available. The control samples were subjected to conventional heating using a Peltier plate method; this heating method resulted in approximately 95% viability.